The UK CARDIO-IMID Partnership is an initiative that brings together experts in cardiovascular and immune-mediated inflammatory diseases across 32 centres in the UK.

Our mission is to transform the management of cardiovascular involvement of people with IMIDs through better understanding of inflammation science of cardiovascular disease, enhanced diagnostics and monitoring and precision therapeutics. This will be achieved by establishing a world class patient-centred, dynamic and sustainable, collaborative UK infrastructure in cardio-rheumatology to conduct scalable experimental medicine research and targeted therapeutic trials. We are also delivering bespoke educational content, provided by world-leading experts in the field, via the UK CARDIO-IMID Hub to train the next generation of cardio-rheumatology clinicians, researchers, and HCPs.

UK CARDIO-IMID Hub

Sam Killen

Introduction to cardio-rheumatology, IMIDs, and an overview of the course modules.

1a. An introduction to cardio-rheumatology & the CARDIO-IMID educational platform

Introduction to CVD in IMID patients, focusing on inflammation, atherosclerosis, and imaging.

1b. Primer - CVD: ASCVD, inflammatory cardiomyopathy, HF, valvular disease

Overview of Rheumatic IMIDs, their treatments, and cardiac complications.

1c - Primer - Rheumatic IMIDs

The role of the immune system and inflammation in ischemic cardiovascular disease.

1d - Immune basis and targeted management of ischaemic CVD  in general population CVD

Exploring how inflammation and immune pathways contribute to cardiomyopathy.

1e - Immune basis of inflammatory cardiomyopathy/non-ischaemic CVD in general population

Introduction to Cardio-Rheumatology&nbsp;establishes the clinical and scientific groundwork — covering core cardiovascular conditions seen in IMID patients, the key rheumatic diseases driving them, and the immune mechanisms underpinning both ischaemic and non-ischaemic cardiovascular disease.